Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

33.73
-0.0200-0.06%
Volume:841.16K
Turnover:28.46M
Market Cap:3.90B
PE:-15.91
High:34.38
Open:33.49
Low:33.49
Close:33.75
52wk High:43.15
52wk Low:18.92
Shares:115.55M
Float Shares:110.00M
Volume Ratio:0.53
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1195
EPS(LYR):-3.1920
ROE:-47.34%
ROA:-30.27%
PB:6.10
PE(LYR):-10.57

Loading ...

Feb 11, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 22, 2025

Major Issues Report

Form 8-K - Current report
Aug 19, 2025

Major Issues Report

Form 8-K - Current report
Jul 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 23, 2025

Major Issues Report

Form 8-K - Current report
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]